Real-world evidence on cenobamate monotherapy in epilepsy
Why real-world data matters in epilepsy research Epilepsy affects millions of adults in the United...
Why real-world data matters in epilepsy research Epilepsy affects millions of adults in the United...
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
Why data provenance matters for regulatory submissions and clinical trials Regulators increasingly...
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S. have obesity, representing over 100 million patients.1 Not long ago, bariatric surgery was the only option for substantial weight loss among those with ...